{"name":"Sancilio and Company, Inc.","slug":"sancilio-and-company-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxNU1JUbVltZVRMay1CRjlNS3h5THdxdlBpUXF3dXlVdENBMm9TWHZzZUZ5Vk5ZdS0wazB5SWk1aXQxbkdSNEh0aC1MSW85eUlkX0J1bGlKWVhVbFdSZ1poNDVITFIzYV93NTZXTURUbklQVVFxOHZsNndra0Jlald0bHJwcVc5bmRzaktJOWNXVlRKaTNIbEhmdUt5a2liUkM2bHBUZWhFbVNaNm5XT25NMnRId1I2ZTRObVZSU0k4TEowbGJDNTg3OUtRMl9EaXNGUVVzdTVYTDdRN3R1Y3Y5M25uZkhkM25GME9fdmNYTGV3bkZtbjU4T0tTVjNxWk84cDB4bXVZUnowMUR5TVkyMzNIdUFEMnZ4LWJ6eVZB?oc=5","date":"2024-10-16","type":"trial","source":"businesswire.com","summary":"Lobe Sciences, Ltd. Announces the Appointment of Enclave Capital and Peak Asset Management to Fund Clinical Trials of Conjugated Psilocin™ - businesswire.com","headline":"Lobe Sciences, Ltd. Announces the Appointment of Enclave Capital and Peak Asset Management to Fund Clinical Trials of Co","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxOU1FRaG9FY2ViVjlrVW42bDkzSHY5NlhNMEQyQzY0b1VoZnJRVnhPNkx5RFFxM213NkNDVHNyeEthdmhyUkhIa0hNdEZLOTdoekhoX3FuVnFTWG03Y0Z4NlJIaVp6aXpJdXV3dHZseHZBclNYY3lheER4c2xKb1pfUDBMVkFkTnVuQW9lcTl5bWlwN0hYZGc1UTgwbEhrN3ZITkVhZVNVVHJGLU4yUDVFMmRndFJxZm1QdW5zcXJucEdsRDNGS2phQjFJZlZQUmc?oc=5","date":"2024-08-15","type":"pipeline","source":"businesswire.com","summary":"Lobe Sciences Announces Creation of Wholly Owned Subsidiary, Alera Pharma, Inc. - businesswire.com","headline":"Lobe Sciences Announces Creation of Wholly Owned Subsidiary, Alera Pharma, Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxNcTJLWmk4eUpnTmFtdVRtbUVWcTVTQVNJemdRZ1ZvQ0x3ZGRaWl9vallRbUV2aC1RYUR4RW44QmtTT3NrV2tHcnlIV3pjR0FyUk1NLTgwczRPYWZjeVZyaXpoUnREWG5kaG1rOGZKTGY3ZU5VemRYSnNmT0JacUVCd0E0cE8xU0VkMm13Z0k1NGpwc3FuSVZnVUZfSUNta09wbXRhcldEUjg3UTFRX3NBTTVkbEdpVlBaYWVmQUd6TDdLeGdybk9DQ0NZUEk3YmhsX3lxMGltVkpLQUZvdl9MUXY5bm03X0xYMjkzcnZXZzVxSVdEeVlJbTFYRQ?oc=5","date":"2024-05-21","type":"pipeline","source":"businesswire.com","summary":"Lobe Sciences Ltd. and Clearway Global Announce Change of Control and Focus on Creating Value for Shareholders - businesswire.com","headline":"Lobe Sciences Ltd. and Clearway Global Announce Change of Control and Focus on Creating Value for Shareholders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxPZFlTU1pPOEI1V0FkeFQ4TjcxdGdUUFhsQjg0dXlDZUd4eXZyUzVUaUtjeGdJcXdYSFlMMmdaSTJrT0JlTl9aRzUtdFY2c3hKeGlCMlJvSW5JQmJSN2h4dzkzd0NPWGsxQWstQ0VaazZvb0NvNWg4ZzJCU3hfaTlCUS13VWNpUXZkUXRkbmtnc0VHOGd5X2pBdnAzWUdYN2dmUDFUbEdaeWhtOUh0SUFoelFGZEg5VVBjTklJQzhCUmszNnBFSjlv?oc=5","date":"2020-08-28","type":"pipeline","source":"Black PR Wire","summary":"Altemia™ Achieves Successful Clinical Results in Pediatric Patients with Sickle Cell Disease (SCD) - Black PR Wire","headline":"Altemia™ Achieves Successful Clinical Results in Pediatric Patients with Sickle Cell Disease (SCD)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPZ3B5dVVEVS1hS0g5Ym55S3lfUUM5SlpaQ0lQelViZTZxLWpLcXBzUlRjMHRtYUI1Yk1kNkNILU9qQ01ERGtYdkZyYVFrMHctTGlEWl85VGpTdlJKMjNtR2hGcVljcF8xTHRYbzhTdEpSMmpLM1FPdXNzWWtqbUNka09iVGtGSzlDck9YeHNobWtEejhTWXg2NTBGUGp4Vk00M1RFNXlIZzVzbTRzWVNJ?oc=5","date":"2019-06-12","type":"pipeline","source":"Rheumatology Advisor","summary":"Gout Associated With Hospitalizations for CV and Renal Complications - Rheumatology Advisor","headline":"Gout Associated With Hospitalizations for CV and Renal Complications","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNQUFNaEZtc1ZVZ1RmcGNyVFp0NnhHOHo3UHhyV0szdHpjRkNYQi1oRHdXYllic1hkdDZWRUF4NmpIMlNRVXBNU0VpNUdfYXdHRmYxWUlQNWk1ZmJCc0JxMXpTM3dwVnFwSXRlMHlPQmxUUG1jX3JZdXNlTmdhSkI0NkxibUE2SV9LWkVUZnhieDh6Qy10M3A3YjY5aDZZdzQxQ2hBb1ZnTFdMVU5odkhheTc4N05BTVAydG43RA?oc=5","date":"2019-02-04","type":"pipeline","source":"The Palm Beach Post","summary":"Once a high flier, drug company hit hard times - The Palm Beach Post","headline":"Once a high flier, drug company hit hard times","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxNVVJoVHdhUXNZMkRyTE9DQ2hSWjRfSU9odFAtYWFnUmxxaS1QY2lVT3UyZXV0aEtpU1ZHcmdOR0FBT1Y5VlBYQ0ZhZjU0VHFKaVNvX0ZLX3pvbnhtMTJIU1U5SlBndk5UYnI5M01WM2VmTzF3VUFWbTFqbXVLcTFXM0pURG4?oc=5","date":"2018-05-17","type":"pipeline","source":"European Biotechnology Magazine","summary":"Aldevron Names Marc Wolff CFO - European Biotechnology Magazine","headline":"Aldevron Names Marc Wolff CFO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE14U1lKV3ZKd3ZubHBXc0x6QVpGUnJzU1EydzhZREs4bTNVNHFfbERmSHlaMzBkRDZSZ3RyNVN5UkZlbHlQakl5S3ZDWDQtaC1UcUlVWHphTkZ6OTFpOG5DUW9HaHppd2dQQzNZSFoybFFPUmpEcVBUcGlFS21fdkk?oc=5","date":"2018-05-15","type":"pipeline","source":"BioSpace","summary":"Aldevron Names Marc Wolff Chief Financial Officer - BioSpace","headline":"Aldevron Names Marc Wolff Chief Financial Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOaFJyMHRiRjV0SFBBd0tqLUJRdU9FVjFIcXpiSFV0bUpESTh5d2dkY0E3UDVPaVdLbFE2ZkI0VVFFRWNKLVUyNTR1OFFxTl9qM2RWSi1fUUVvSE9SRFZCYTFKdDJROEZpeG9GYzh2bEhWcU9jLVc3aDNqUFNZS3RSWTI2NXVxTHBOdGgxYnZ1d0haMEVQTElpQlNhalhqQ1VSb2V1c2FPd1MwQQ?oc=5","date":"2016-01-19","type":"pipeline","source":"newswire.com","summary":"Ocean Blue, Announces the Winner of the Why I Love Ocean Blue Omega∙3 Contest - newswire.com","headline":"Ocean Blue, Announces the Winner of the Why I Love Ocean Blue Omega∙3 Contest","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPTWNJYllQT3RKT3lmV2dqQWN1LTdyanp2V1FJLWxIX3czckVRUkZiRFpSSXIyWS1GN1lOWGc4YTNrRkEtV1I4Zi1YZzQ2UFFzdEh0SXRvS2UwMm1tc1JmNjRYNUk0cjlhTWZCMFdCWHZ4bE1rMG5HSUwzcGp4TlFwNTVWLW90QlpkZWN1N1J0ZmwxcWdDUWhKNEMwWnBkanpqbzA5NU1TMXV2Zw?oc=5","date":"2013-09-07","type":"pipeline","source":"The Palm Beach Post","summary":"Bustling drug manufacturer thriving in Riviera Beach - The Palm Beach Post","headline":"Bustling drug manufacturer thriving in Riviera Beach","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}